Psychosoziale Folgen bei Langzeitüberlebenden einer Krebserkrankung

Leitthema

Zusammenfassung

Trotz steigender Inzidenzzahlen für Tumorerkrankungen zeigen die Statistiken der letzten Jahre zunehmend verbesserte Heilungsraten sowie erhöhte Überlebenszeiten bei den meisten Tumorarten. Dies ist Resultat einer verbesserten Früherkennung und vor allem verbesserter Behandlungsmöglichkeiten. Entsprechend hat die Zahl der Langzeitüberlebenden nach einer Tumorerkrankung zugenommen, die allerdings erst in den letzten Jahren Gegenstand psychosozialer Forschungsinteressen wurden. Erste Studien zeigen, dass ein Großteil der Tumorpatienten wieder eine gute Lebensqualität erreichen kann, die mit der der Normalbevölkerung vergleichbar ist. Dennoch bleiben die Lebensqualität sowie psychische Befindlichkeit bei einem Teil der Patienten infolge der Erkrankung und/oder Behandlung auch langfristig erheblich eingeschränkt. Die vorliegende Übersichtsarbeit konzentriert sich auf die Darstellung der am häufigsten in der Forschungsliteratur dokumentierten Folgeprobleme wie die psychischen Probleme, das tumorassoziierte Fatiguesyndrom und neurokognitive Leistungseinschränkungen. In einem abschließenden Fazit werden Fragen zum psychosozialen Behandlungsbedarf erörtert und Schlussfolgerungen für die psychosoziale Versorgung gezogen.

Schlüsselwörter

Psychische Befindlichkeit Langzeitüberlebende Krebs Fatigue Neuropsychologische Leistungseinschränkungen 

Psychosocial issues of long-term cancer survivors

Abstract

Although cancer incidence rates are increasing, recent statistical studies suggest that cancer patients are showing higher cure rates as well as improved overall survival rates for most cancer locations. These advances are explained by improved strategies in early diagnoses as well as improved cancer therapies. Therefore, the number of long-term cancer survivors has also increased, but only few studies, especially within the last years, have focused on psychosocial issues of this subgroup. Some studies show that overall quality of life of long-term cancer survivors is quite high and comparable to that of the normal population. Nevertheless, a substantial percentage of former patients shows reduced quality of life and suffers from various sequelae of cancer and its treatment. This review focuses on the most common psychosocial issue of long-term survivors such as reduced psychological wellbeing, neuropsychological deficits and cancer-related fatigue syndrome. Finally, recommendations for problem-oriented interventions as well as improvement of psychosocial care of long-term survivors are given.

Keywords

Psychosocial wellbeing Long-term survivors Cancer Fatigue Neurocognitive dysfunctions 

Literatur

  1. 1.
    Robert Koch-Institut (2012) Krebs in Deutschland 2007/2008, 8. Aufl. Robert Koch-Institut, Berlin. http://www.rki.de/krebsGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Ward E et al (2008) Cancer statistics 2008. Cancer J Clin 58:71–96CrossRefGoogle Scholar
  3. 3.
    Faller H (2008) Krankheitsverarbeitung bei Krebskranken. Hogrefe, GöttingenGoogle Scholar
  4. 4.
    Hewitt M, Greenfield S, Stovall E (Hrsg) (2006) From cancer patient to cancer survivor. National Academic Press, WashingtonGoogle Scholar
  5. 5.
    Moyer A, Salovey P (1996) Psychosocial sequelae of breast cancer and its treatment. Anna Behavioral Med 18:110–125CrossRefGoogle Scholar
  6. 6.
    Herschbach P, Berg P, Dankert A et al (2005) Fear of progression in diabetes mellitus, cancer and chronic arthritis – psychometric properties of the fear of progression questionnaire (FoP-Q). J Psychosom Res 58:505–511PubMedCrossRefGoogle Scholar
  7. 7.
    Park CL (2010) Making sense of the meaning literature: an integrative review of meaning making and its effects on adjustment to stressful life events. Psychol Bull 136:257–301PubMedCrossRefGoogle Scholar
  8. 8.
    Kernan WD, Lepore SJ (2009) Searching for and making meaning after breast cancer: prevalence, patterns, and negative affect. Soc Sci Med 68:1176–1182PubMedCrossRefGoogle Scholar
  9. 9.
    Manne S, Ostroff J, Fox K et al (2009) Cognitive and social processes predicting partner psychological adaptation to early stage breast cancer. Br J Health Psychol 14:49–68PubMedCrossRefGoogle Scholar
  10. 10.
    Helgeson VS, Reynolds KA et al (2006) A meta-analytic review of benefit finding and growth. J Consult Clin Psychol 74:797–816PubMedCrossRefGoogle Scholar
  11. 11.
    Park CL, Chmielewski J, Blank TO (2009) Post-traumatic growth: finding positive meaning in cancer survivorship moderates the impact of intrusive thoughts on adjustment in younger adults. Psychooncology 19:1139–1147Google Scholar
  12. 12.
    Bardwell WA, Major JM, Rock CL et al (2004) Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology 13:595–604PubMedCrossRefGoogle Scholar
  13. 13.
    Helgeson VS, Tomich PL (2005) Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 14:307–317PubMedCrossRefGoogle Scholar
  14. 14.
    Kornblith AB, Powell M, Regan MM et al (2007) Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology 16:895–903PubMedCrossRefGoogle Scholar
  15. 15.
    Bolin K (2008) Health among long-term survivors of breast cancer – an analysis of 5-year survivors based on the Swedish surveys of living conditions 1979–1995 and the Swedish Cancer Registry 2000. Psychooncology 17:1–8PubMedCrossRefGoogle Scholar
  16. 16.
    Michael YL, Berkman LF, Colditz GA et al (2002) Social networks and health-related quality of life in breast cancer survivors. A prospective study. J Psychosom Res 52:285–293PubMedCrossRefGoogle Scholar
  17. 17.
    Burgess C, Ramirez A, Cornelius V et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330:702–705PubMedCrossRefGoogle Scholar
  18. 18.
    Tomich PL, Helgeson VS, Novak Vache EJ (2005) Perceived growth and decline following breast cancer: a comparison to age-matched controls 5-years later. Psychooncology 14:1018–1029PubMedCrossRefGoogle Scholar
  19. 19.
    Bloom JR, Peterson DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706PubMedCrossRefGoogle Scholar
  20. 20.
    Ganz PA, Desmond KA, Leedham B et al (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMedCrossRefGoogle Scholar
  21. 21.
    Ahmed RL, Prizment A, Lazovich D et al (2008) Lymphedema and quality of life in breast cancer survivors: The Iowa Women’s Health Study. J Clin Oncol 26:5689–5696PubMedCrossRefGoogle Scholar
  22. 22.
    Kornblith AB, Herndon JE, Weiss RB et al (2003) Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 98:679–689PubMedCrossRefGoogle Scholar
  23. 23.
    Herschbach P (2002) Das „Zufriedenheitsparadox“ in der Lebensqualitätsforschung. Wovon hängt unser Wohlbefinden ab? Psychother Med Psychol 52:141–150CrossRefGoogle Scholar
  24. 24.
    Schwartz CE, Andresen EM, Nosek MA et al (2007) Expert Panel on Health Status Measurement. Response-shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 88:529–536PubMedCrossRefGoogle Scholar
  25. 25.
    Oort FJ (2005) Using structural equation modeling to detect response-shift and true change. Qual Life Res 14:587–598PubMedCrossRefGoogle Scholar
  26. 26.
    Ganz PA (1998) Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? (Editorial) J Natl Cancer Inst 90:182–183Google Scholar
  27. 27.
    Poppelreuter M, Weis J, Külz AK et al (2004) Cognitive dysfunction and subjective complaints of cancer patients: a cross sectional study in a cancer rehabilitation center. Eur J Cancer 40:43–49PubMedCrossRefGoogle Scholar
  28. 28.
    Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvat chemotherapy for breast cancer. Cancer 109(9):1905–1913PubMedCrossRefGoogle Scholar
  29. 29.
    Poppelreuter M, Weis J, Mumm A et al (2007) Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 41:79–90PubMedCrossRefGoogle Scholar
  30. 30.
    Mehnert A, Scherwath A, Schirmer L et al (2011) Kognitiver Funktionsstatus bei Patienten mit Leukämien und Lymphomerkrankungen im ersten Jahr nach allogener hämatopoetischer Stammzelltransplantation – Eine prospektive Längsschnittstudie. DRV-Schriften 93:405–406Google Scholar
  31. 31.
    Bender CM, Paraska KK, Sereika SM et al (2001) Cognitive function and reproproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manage 21:407–424PubMedCrossRefGoogle Scholar
  32. 32.
    Shilling V, Jenkins V, Fallowfield L et al (2001) The effects of oestrogens and anti-oestrogens on cognition. Breast 10:484–491PubMedCrossRefGoogle Scholar
  33. 33.
    Tchen N, Juffs HG, Downie FP et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183PubMedCrossRefGoogle Scholar
  34. 34.
    Alibhai SMH, Breunis H, Timilshina N et al (2010) Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 28:5030–5037PubMedCrossRefGoogle Scholar
  35. 35.
    Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299PubMedCrossRefGoogle Scholar
  36. 36.
    Poppelreuter M, Weis J, Bartsch HH (2009) Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy. J Psychosoc Oncol 27(2):274–296PubMedCrossRefGoogle Scholar
  37. 37.
    Cheville AL (2009) Cancer-related fatigue. Phys Med Rehabil Clin Am 20:405–415CrossRefGoogle Scholar
  38. 38.
    Rüffer JU, Flechtner H, Tralls P et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39(15):2179–2186PubMedCrossRefGoogle Scholar
  39. 39.
    Kuhnt S, Ernst J, Singer S et al (2009) Fatigue in cancer survivors – prevalence and correlates. Onkologie 32(6):312–317PubMedCrossRefGoogle Scholar
  40. 40.
    Arndt V, Merx H, Stegmaier C et al (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in woman with breast cancer. J Clin Oncol 23(22):4945–4953PubMedCrossRefGoogle Scholar
  41. 41.
    Mehnert A, Scherwarth A, Schirmer L et al (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high dose chemotherapy. Patient Educ Couns 66:108–118PubMedCrossRefGoogle Scholar
  42. 42.
    Andrykowski MA, Donovan KA, Laronga C et al (2010) Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer 116:5740–5748PubMedCrossRefGoogle Scholar
  43. 43.
    NCCN (National Comprehensive Cancer Network) (2011) Clinical practice guidelines in oncology: cancer related fatigue. Version 1.2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.aspGoogle Scholar
  44. 44.
    Bower JE (2007) Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21:863–871PubMedCrossRefGoogle Scholar
  45. 45.
    Schubert C, Hong S, Natarajan L et al (2007) The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 21:413–427PubMedCrossRefGoogle Scholar
  46. 46.
    Strasser F, Palmer JL, Schover LR et al (2006) The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 107:2949–2957PubMedCrossRefGoogle Scholar
  47. 47.
    Berger AM, Wielgus K, Hertzog M et al (2010) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18:105–114CrossRefGoogle Scholar
  48. 48.
    Rich TA (2007) Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 5:167–174PubMedGoogle Scholar
  49. 49.
    Miller AH, Ancoli-Israel S, Bower JE et al (2008) Neuroendocrine immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971–982PubMedCrossRefGoogle Scholar
  50. 50.
    Ancoli-Israel S, Moore PJ, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 10:245–255Google Scholar
  51. 51.
    Loge J, Abrahamsen A, Ekeberg O et al (2000) Fatigue and psychiatric morbidity among Hodgkin’s disease survivor. J Pain Symptom Manage 19(2):91–99PubMedCrossRefGoogle Scholar
  52. 52.
    Patrick DL, Ferketich SL, Frame PS et al (2003) National institutes of health state-of-the-science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst 95:1110–1117PubMedCrossRefGoogle Scholar
  53. 53.
    Valentine A, Meyers C (2001) Cognitive and mood disturbance as causes and symptoms of Fatigue in cancer patients. Cancer 92(6 suppl):1694–1698PubMedCrossRefGoogle Scholar
  54. 54.
    Visser M, Smets E (1998) Fatigue, depression and quality of life in cancer patients: How are they related? Support Care Cancer 6:101–108PubMedCrossRefGoogle Scholar
  55. 55.
    Ashbury F, Findlay H, Reynolds B et al (1998) A Canadian survey of cancer patients‘ experiences: Are their needs being met? J Pain Symptom Manage 16(5):298–306PubMedCrossRefGoogle Scholar
  56. 56.
    Spelten ER, Verbeek JAHM, Uitterhoeve ALJ et al (2003) Cancer, fatigue and the return of patients to work – a prospective cohort study. Eur J Cancer 39:1562–1567PubMedCrossRefGoogle Scholar
  57. 57.
    Cramp F, Daniel J (2008) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev:CD006145Google Scholar
  58. 58.
    Jacobsen PB, Donovan KA, Vadaparamil ST et al (2007) Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol 26:660–667PubMedCrossRefGoogle Scholar
  59. 59.
    Goedendorp MM, Gielissen MF, Verhagen CA et al (2009) Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev:CD006953Google Scholar
  60. 60.
    Minton O, Richardson A, Sharpe M et al (2010) Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 7:CD006704PubMedGoogle Scholar
  61. 61.
    Syrjala K, Artherholt S, Kurland B et al (2011) Prospective neurocognitive function over 5 years after allogeneic hematopoetic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol 29(17):2397–2404PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2012

Authors and Affiliations

  1. 1.Klinik für Tumorbiologie an der Universität FreiburgFreiburgDeutschland
  2. 2.Institut für Psychotherapie und Medizinische PsychologieUniversität WürzburgWürzburgDeutschland

Personalised recommendations